PANCREATIC CANCER CURE FOUNDATION (EIN 815164082) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

STEPHEN CYGAN

Phone

2157830502

Tax Period

2023-10-01 to 2024-09-30

PANCREATIC CANCER CURE FOUNDATION, founded in 2016, is a micro nonprofit in the Medical Research sector that reported $78K in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $73K left a modest 6% surplus.

Mission

PANCREATIC CANCER CURE FOUNDATION'S MISSION IS TO RAISE MONEY AND DISTRIBUTE FUNDING PRIMARILY TOWARDS PANCREATIC CANCER RESEARCH AND COMPASSIONATE CARE INITIATIVES, AND, TO A LESSER EXTENT, AWARENESS AND ADVOCACY EFFORTS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $78,505

Program Service Revenue $0

Investment Income $41

Other Revenue $-901

TOTAL REVENUE $77,645

Expense Breakdown

Grants Paid $63,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $63,000

Other Expenses $10,144

TOTAL EXPENSES $73,144

Year-over-Year Comparison

	2023	2022	Change
Revenue	$77,645	$69,855	+0.1%
Expenses	$73,144	$79,533	-0.1%
Net Income	$4,501	$-9,678	-1.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL CYGAN	DIRECTOR	5.00	Director	$0	$0	$0
ANTHONY CYGAN	VICE PRESIDENT	3.00	Officer Director	$0	$0	$0
DAVID CYGAN	SECRETARY	5.00	Officer Director	$0	$0	$0
JANE CYGAN	TREASURER	10.00	Officer Director	$0	$0	$0
STEPHEN CYGAN	PRESIDENT	3.00	Officer Director	$0	$0	$0
NATHAN CYGAN	DIRECTOR	3.00	Director	$0	$0	$0
GREGORY CYGAN	DIRECTOR	4.00	Director	$0	$0	$0
MARLENE MAYZA	DIRECTOR	3.00	Director	$0	$0	$0
CELESTE VAUGHN	DIRECTOR	8.00	Director	$0	$0	$0
LAURA DEPENBUSCH	DIRECTOR	8.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$77,645	$73,144	$6,424	$4,501
2023	$69,855	$79,533	$1,923	$-9,678
2022	$79,330	$76,672	$11,601	$2,658
2021	$77,288	$78,260	$8,943	$-972
2020	$38,209	$39,906	$9,915	$-1,697
2019	$55,856	$69,146	$11,612	$-13,290
2018	$41,372	$19,784	$24,902	$21,588

PANCREATIC CANCER CURE FOUNDATION